* Treatment of unstable angina (UA) and non-Q-wave myocardial infarction (NQMI), administered concurrently with aspirin * DVT and pulmonary embolism prophylaxis in bed-ridden patients * DVT prophylaxis in knee replacement surgery * DVT prophylaxis in hip replacement surgery * DVT prophylaxis in abdominal surgery * Treatment of DVT with or without pulmonary embolism * Treatment of DVT inpatient, with ST-segment elevation myocardial infarction (STEMI) * Bridging treatment for those with INR below therapeutic range Monitoring<unk>  has predictable absorption, bioavailability, and distribution therefore monitoring is not typically done. However, there are instances where monitoring may be beneficial for special populations, for example individuals with kidney insufficiency or those that are obese. In this case, anti-Xa units can be measured and dosing adjusted accordingly. Reversal agent Protamine sulfate is less effective at reversing<unk>  compared to heparin, with a maximum neutralization of approximately 60% of the anti-factor Xa effect. Pregnancy *<unk>  is a FDA pregnancy category B drug which means<unk>  is not expected to cause harm to an unborn baby when used during pregnancy. This statement is based on reproductive studies involving pregnant rats and rabbits. No birth defects or toxic effects to an unborn fetus due to<unk>  were observed during these animals studies. However a human's response to<unk>  might be different from that of a small animal, therefore<unk>  should be used during pregnancy only if there is a definite need. *<unk>  does not cross the placenta therefore it is unlikely an unborn baby would be exposed to it. * Some fetal deaths have been reported by women who used<unk>  during pregnancy, but it is unclear if<unk>  caused these deaths. * Pregnant woman on<unk>  should be monitored on a regular basis for bleeding and/or "excessive anticoagulation" especially when the delivery date is approaching. The risk of hemorrhage is higher during delivery if the person is still using<unk>  and this could endanger the life of the baby and/or the mother. * The multiple-dose vials of the brand name<unk>  (Lovenox) contain 15 mg benzyl alcohol per 1 mL as a preservative. Premature infants who have been given large amounts of benzyl alcohol (99–405 mg/kg/day) have experienced "gasping syndrome". * Although<unk>  is used to prevent blood clots, pregnancy alone can raise a woman's risk of clotting.
Enoxaparin sodium
Apixaban
Palladin
Dabigatran
Cilostazol
Ticlopidine
Rivaroxaban
Pitavastatin